Skip to content

A 1816 · New Jersey · 222 · Billy

Skip to content

Home
/
Bills
/
New Jersey
/
222
/
A 1816

New Jersey · 222 session · house

A 1816Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.

Status: In committee
Latest action: 2026-01-13 — Introduced, Referred to Assembly Health Committee
Primary sponsor: Verrelli, Anthony S. (Democratic)

Health

Track this bill

Sponsors

Verrelli, Anthony S. (Democratic) · primaryprimary
Fantasia, Dawn (Republican) · primaryprimary
Speight, Shanique (Democratic) · cosponsor

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New Jersey bill RSS

Tully, Chris (Democratic) · cosponsor

Versions

IntroducedJan 13, 2026

Legislative history

Jan 13, 2026
Introduced, Referred to Assembly Health Committee

Official sources

Version 0PDF HTML

About this page

Is this the official New Jersey bill page?: No — this is Billy’s public legislative record for A 1816. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track A 1816, get alerts, annotate diffs, and export Word work product.